AstraZeneca joins CACHE Governing Board

We are pleased to announce that AstraZeneca, a global, science-led biopharmaceutical company has joined the CACHE (Critical Assessment of Computational Hit-finding Experiments) Governing Board for a two-year term, which is a critical element of Conscience’s efforts to set clear industry-leading benchmarks and improve success rates in the current drug discovery system. Bringing a wealth of […]

Get to Know Our Partnerships Lead, Lauriane

Lauriane Gorce

We are excited to share a new podcast episode featuring Lauriane Gorce, Conscience’s Partnerships Lead, on Papa PhD, which aims to help students thrive beyond academia. Lauriane met David at a networking event and joined the podcast to share her journey and insights on finding a fulfilling career that balances societal impact, work, and personal […]

CACHE Challenge #2 identifies seven ‘hits’ for pan-coronavirus treatment

coronavirus

In our second CACHE Challenge, researchers from across the globe identified seven promising early-stage molecules that could lead to a new treatment effective against all coronaviruses, advancing preparedness for future pandemic threats. For more information, contact:Estrid Jakobsen at [email protected] Preeti Singh at [email protected] Conscience Announces Top Performers in Open Science Challenge to Design Promising Pan-Coronavirus Drugs […]

Upcoming Request for Proposals: Developing Medicines through Open Science

Person Holding Laboratory Flask

We are excited to announce Conscience’s upcoming Request for Proposals for the Developing Medicines through Open Science program! This initiative is designed to foster collaborative drug discovery and development in areas often overlooked by the pharmaceutical industry, such as orphan diseases and antimicrobial resistance. The inaugural round of this program will offer a total of […]

Conscience Logo